examples

examples

examples

vaccination program

Malaysia's

When can you expect to receive the Covid-19 vaccination? for more information.

500,000

Healthcare frontliners and essential workers

9.4mil

senior citizens and high risk group

13.7mil/more

malaysian & non-malaysian citizens aged 18 years and above

Phase 1

Feb to Apr 2021

phase 2

Apr to Aug 2021

phase 3

May 2021 to Feb 2022

Types of vaccines

mRNA

Viralvector

challenges

advantages

challenges

challenges

advantages

Inactivated virus

Source: Health Ministry & Akademi Sains Malaysia

FAQ

advantages

for more information.

Click on the ->

How it works

Click on the icons below

How it works

Click on the textbelow

how it works

to navigate to the next page.

Viruses that have been killed using high temperature, chemical or radiation.Inactivated virus vaccine Malaysia has acquired:• Sinovac

Contains viruses that have been modified (vector) to convey the genetic code of the antigen.Viral vector vaccines Malaysia has acquired:• AstraZeneca• CanSino Biologics• Sputnik V

The mRNA sequence is inserted into individual cells to produce specific virus proteins.mRNA vaccines Malaysia has acquired:• Pfizer-BioNTech

• Using virus which are killed to stimulate an immune response.

• Proven technology• No live components• Suitable for those with weak immune systems• Easily produced

High cost to produce

Polio, Japaanese encephalitis and rabies

Ebola, Vaccines for farm animals

• Complex manufacturing process• Important to make sure viral vector used is safe

• Proven technology• Triggers an adaptive immunity response that is more effective

• Using viral vectors which are not dangerous to deliver the genetic material targeting the virus so that it stimulates an immune response.

None

• Some mRNA vaccines require extremely cold storage conditions• Used for the first time as a vaccine in medical history

• Produced easily and quickly• No live components, synthetically produced• Triggers an adaptive immune response

Uses mRNA molecules to stimulate immunity to recognise protein of the targeted virus.

Phase Two of the vaccination programme will involve two groups:Group 1The remaining healthcare frontliners, frontline essential workers and defense workers.Group 2Senior citizens aged 60 and above, high-risk group with chronic illnesses such as heart disease, obesity, diabetes, high blood pressure and the disabled.

Phase One of the vaccination programme will involve two groups:Group 1Government and private healthcare frontlinersGroup 2Frontline essential workers and the defense team

Malaysian and non-Malaysian citizens aged 18 years and above. Priority will be given to those living in red zones, followed by the yellow zones and lastly the green zone.

Contains viruses that have been modified (vector) to convey the genetic code of the antigen.Viral vector vaccines Malaysia has acquired:• AstraZeneca• CanSino Biologics• Sputnik V

The mRNA sequence is inserted into individual cells to produce specific virus proteins.mRNA vaccines Malaysia has acquired:• Moderna• Pfizer/BioNTech

Viruses that have been killed using high temperature, chemical or radiation.Inactivated virus vaccine Malaysia has acquired:• Sinovac

• Produced easily and quickly• No live components, synthetically produced• Triggers an adaptive immune response

The mRNA sequence is inserted into individual cells to produce specific virus proteins.mRNA vaccines Malaysia has acquired:• Moderna• Pfizer/BioNTech

Contains viruses that have been modified (vector) to convey the genetic code of the antigen.Viral vector vaccines Malaysia has acquired:• AstraZeneca• CanSino Biologics• Sputnik V

Viruses that have been killed using high temperature, chemical or radiation.Inactivated virus vaccine Malaysia has acquired:• Sinovac

None

• Some mRNA vaccines require extremely cold storage conditions• Used for the first time as a vaccine in medical history

Ebola, Vaccines for farm animals

• Proven technology• Triggers an adaptive immunity response that is more effective

• Complex manufacturing process• Important to make sure viral vector used is safe

Polio, Japaanese encephalitis and rabies

• Proven technology• No live components• Suitable for those with weak immune systems• Easily produced

Covid-19 vaccine

what is Covid-19?

frequently asked questions About The

Source: Health Ministry & Akademi Sains Malaysia

who is eligible to receive the covid-19 vaccine?

what are the effects of the covid-19 vaccine?

will the vaccine stop the pandemic?

what DO you need to know before receiving the vaccine?

what is a Covid-19 vaccine?

Click on the textbelow

for more information .

The Coronavirus 2019 (COVID-19) is caused by a coronavirus variant infection known as SARS-CoV-2. The virus can cause infection in the airways that may cause symptoms ranging from common cold to severe pneumonia.

All individuals aged 18 years and above.However, some groups need further evaluation in order to receive the vaccine, namely:1) Individuals with severe allergies2) Pregnant individuals and nursing mothers3) Covid-19 positive individuals4) Individuals with complications involving the immune systemCurrently, most of the clinical trials conducted are for volunteers aged 18 and above. Some vaccine companies will conduct clinical trials on children. Therefore, the government will consider the use of Covid-19 vaccine in children when there is scientific data that proves its effectiveness and safety to this group.

The side effects of the Covid-19 vaccine that have been reported are mild and temporary. The most commonly reported side effects are:Pain / swelling / redness at the injection siteTirednessHeadacheShiveringJoint painFeverNauseaFeeling unwellSwelling of the lymph nodesSide effects that may be reported from time to timeSide effect monitoring / Adverse event following immunization (AEFI) will be conducted through enhanced surveillance where vaccine recipients will be given scheduled notifications / reminders through the MySejahtera application to report any side effects experienced. AEFI reporting can also be made by health workers through the existing system.A serious investigation into AEFI will be conducted carefully, with a special committee by experts set up to assess AEFI cases and safety issues related to the Covid-19 vaccine.

Recipients need to complete the Covid-19 vaccine schedule using the same brand according to the specified time period.Tell your doctor or nurse before you are vaccinated if you are:Individuals with severe allergiesPregnant individuals and nursing mothersCovid-19 positive individualsIndividuals with complication involving the immune system

The use of the Covid-19 vaccine is one of the steps taken to stop the pandemic. However, compliance with SOPs and the practice of new norms such as hygiene practices, wearing face masks and physical distancing still needs to be practiced until as many residents as possible receive the vaccine.

The Covid-19 vaccine stimulates the immune system so that if the body were exposed to the SARS-CoV-2 coronavirus, it can respond to the Covid-19 infection. Various platforms such as RNA genetic sequencing, viral vectors, deactivated viruses and protein sub-units have been used to provide safe and effective coronavirus vaccines. It gives you the best protection against Covid-19.